Among chronic headaches, migraine is a common neurological disorder, which is typically characterized by severe pain on one or both sides of the head and disturbances in vision. 1) Headache symptoms, such as restrictions on activities in daily life, persistent discomfort, and decreased concentration, place a burden on people's lives. 1) Accordingly, many patients rely on over-the-counter (OTC) drugs for the treatment of symptoms. 2,3) According to the OverCOME study, only 57.4% of people with migraine visited a medical facility, 14.8% were currently using triptan preparations, and 9.2% were currently using prophylactic drugs. 3) Therefore, the role of pharmacists who sell OTC drugs for headache treatment is extremely important from the perspective of increasing the rate of medical examinations for migraine patients.Among chronic headaches, medication overuse headaches (MOH) are often associated with migraine patients. MOH is an intractable headache that is triggered when analgesics are taken in excess. 4) Treatment for MOH at a headache outpatient clinic, neurology, neurosurgery, or pain clinic that specializes in headaches requires that the treatment and guidance be tailored to each patient's progress. Many cases of MOH in Japan are caused by OTC analgesics; 5) therefore, it is necessary for pharmacists in pharmacies to make an assessment of whether the headache patient has MOH based on their symptoms and complaints, when selling OTC analgesics.A Tracing Report (TR) 6) is a document that conveys information collected from patients. TR is considered important in terms of the effectiveness and safety of drug therapy. For pharmacists, "shifting from dealing with materials to dealing with people," and collaboration between pharmacies and medical facilities is becoming more important. Thus, the use of TRs is attracting attention as an information provision and collaboration tool. With the advent of TRs, it has become possible to follow up patients being treated with prescription drugs through medical collaboration. However, there is no way to coordinate medical care to monitor patients who are being treated with OTC drugs for headaches.In this study, we conducted a questionnaire survey of people who were aware of their headaches in order to clarify the current state of headache treatment and the involvement of pharmacists in headache treatment.
METHODS
Questionnaire StudyWe used Cross Marketing Inc., an Internet research company, to recruit subjects. The subjects were in their 20s to 40s and had headaches in the past 3 months. The Internet research company sent questionnaire request emails to registered monitors (9,129 people), and 995 people responded to the screening. In this survey, we enrolled